{"id":"W2922191218","doi":"10.1200/jco.2019.37.7_suppl.428","title":"Avelumab treatment in metastatic urothelial carcinoma: Post-hoc analysis of high-risk populations in the phase Ib JAVELIN Solid Tumor Study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Avelumab; Metastatic Urothelial Carcinoma; Internal medicine; Javelin; Response Evaluation Criteria in Solid Tumors; Oncology; Adverse effect; Urology; Neutropenia; Gastroenterology; Chemotherapy; Phases of clinical research; Cancer; Urothelial carcinoma; Immunotherapy; Bladder cancer; Nivolumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006265305,0.0007828988,0.002030279,0.0003495812,0.0003379102,0.001030599,0.0007072331,0.0005969668,0.001924059],"category_scores_gemma":[0.003619766,0.0003702408,0.003410084,0.0004138132,0.0003986658,0.0006425804,0.0006157858,0.001322294,0.0002831419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005575098,"about_ca_system_score_gemma":0.0009385612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007253081,"about_ca_topic_score_gemma":0.001407963,"domain_scores_codex":[0.9966381,0.002421162,0.0001460562,0.0003594731,0.0001900116,0.0002452797],"domain_scores_gemma":[0.9971726,0.001150965,0.0006641989,0.0003911594,0.0001794559,0.0004414963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7961857,0.002654371,0.1602758,0.0005809625,0.0179314,0.0001860425,0.0001830264,0.001069436,0.004704074,0.0001426122,0.001955576,0.01413102],"study_design_scores_gemma":[0.1500893,0.1571204,0.6440508,0.0001170796,0.02815304,0.0006266949,0.0004021687,0.007518887,0.004345686,0.0004550051,0.007023046,0.000097885],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962484,0.001385054,0.0004210079,0.00009360921,0.00005501207,0.0003897606,0.0008375629,0.00001811581,0.0005515543],"genre_scores_gemma":[0.997098,0.0002628158,0.0004246282,0.0001048269,0.00005571119,0.0003413831,0.001191022,0.00001547404,0.0005060682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006265305,"threshold_uncertainty_score":0.03313446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.145055644120517,"score_gpt":0.4980796812358861,"score_spread":0.3530240371153691,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}